no longer compounding tirzepatide Eli Lilly just issued a public warning to the industry. In a recent open letter, the pharmaceutical company raised concerns about products being combined with vitamin B12 and marketed in compound tirzepatide ban update π’Important
Description
With manufacturers now able to meet national demand, the emergency compounding protocols are ending, and full regulatory oversight is resuming
Gallbladder problems
Brand-name Mounjaro and Zepbound (manufactured by Eli Lilly) are FDA-approved for the indications above
Achieve a slimmer, elongated silhouette
Allergic reactions are uncommon but possible
